Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis
Vasa · 2023
DOI: 10.1024/0301-1526/a001097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vasa, 2023. Verfasst von Julian Kleine Wortmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, University of Zurich, Switzerland. Hauptthemen laut MEDLINE: Venous Thrombosis, Postthrombotic Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Pharmaco-mechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) are therapeutic options for selected patients with acute deep vein thrombosis (DVT) to prevent post-thrombotic syndrome (PTS). Patients and methods: We aimed to describe the clinical characteristics and outcomes of 159 patients with symptomatic iliofemoral DVT undergoing PMT alone, CDT alone, or CDT followed by PMT (bail-out) in the Swiss Venous Stent Registry. The primary outcome was the incidence of peri-interventional major and minor bleeding complications (ISTH criteria). Secondary outcomes included the incidence of PTS and stent patency after 3 years.
Results
Mean age was 49±20 years and 58% were women. DVT involved the iliac veins in 99% of patients, whereas 53% had an underlying iliac vein compression. PMT alone was used in 40 patients, CDT alone in 77, and 42 received initial CDT followed by bail-out PMT due to insufficient thrombus clearance. Single-session PMT was the preferred approach in patients with iliac vein compression, patent popliteal vein, and absence of IVC thrombus. Patients treated with PMT alone received a lower r-tPA dose (median 10 mg, IQR 10-10) vs. those treated with CDT (20 mg, IQR 10-30). The rate of peri-interventional major bleeding was 0%, 1%, and 2%, whereas that of minor bleeding was 0%, 1%, and 12%, respectively, all occurring during CDT. After 3 years, PTS occurred in 6%, 9%, and 7% of patients, respectively. The primary stent patency rate was 95%, 88%, and 83%, respectively.
Conclusions
The use of PMT and CDT for iliofemoral DVT was overall safe and resulted in high long-term patency and treatment success. Given the less severe presentation of DVT, single-session PMT appeared to be characterized by numerically better primary patency and lower perioperative bleeding event rates than CDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Faculty, University of Zurich, Switzerland.
- Department of Angiology, University Hospital Zurich, Switzerland.
- Department of Gastroenterology, Cantonal Hospital Baden, Switzerland.
- Institute of Pharmacology, University of Bern, Switzerland.
ORCID-Profile: Riccardo M Fumagalli, Rahel Cola, Tim Sebastian
Zitieren
APA
Wortmann, J. K., Barco, S., Fumagalli, R. M., Voci, D., Hügel, U., Cola, R., Spirk, D., Kucher, N., & Sebastian, T. (2023). Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis. Vasa. https://doi.org/10.1024/0301-1526/a001097
Vancouver
Wortmann JK, Barco S, Fumagalli RM, Voci D, Hügel U, Cola R, et al. Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis. Vasa. 2023. doi:10.1024/0301-1526/a001097
BibTeX
@article{Wortmann2023,
author = {Wortmann, Julian Kleine and Barco, Stefano and Fumagalli, Riccardo M and Voci, Davide and Hügel, Ulrike and Cola, Rahel and Spirk, David and Kucher, Nils and Sebastian, Tim},
title = {Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis},
journal = {Vasa},
year = {2023},
doi = {10.1024/0301-1526/a001097}
}
EUVIMED